Internal Medicine, Hematology & Oncology · Hershey, PA
NPI
1275219842
Since 2023
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
500 University Dr
Hershey, PA, 17033
Phone (717) 531-8678
Groups this clinician bills Medicare through
Medicare paid, 2024
$43K
562 services
Medicare patients, 2024
127
Average age 71
Drug cost, 2024
$2.3M
620 prescriptions
Company payments, 2025
$3,286
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kentaro Minagawa was code 99214 (office e&m - established), 212 times for 63 patients. In total Kentaro Minagawa billed 562 services in 12 codes, and Medicare paid $43K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-06-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 212 | 63 | $69.89 | $15K |
| 99233 Hospital E&M - Subsequent | Facility | 147 | 36 | $87.69 | $13K |
| 99232 Hospital E&M - Subsequent | Facility | 127 | 25 | $59.63 | $7,573 |
| 99205 Office E&M - New | Facility | 37 | 37 | $131.49 | $4,865 |
| 99239 Hospital Discharge Management | Facility | 16 | 14 | $80.77 | $1,292 |
By year: 2023 $7,893 for 93 services; 2024 $43K for 562 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kentaro Minagawa prescribed most often to Medicare patients was Acyclovir, with 57 prescriptions and refills. In total Kentaro Minagawa wrote 620 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 57 | 100 | 16 | $1,513 |
| Valacyclovir Valacyclovir Hcl | 49 | 108 | 17 | $3,460 |
| Lenalidomide Generic | 27 | 27 | Under 11 | $495K |
| Ursodiol Generic | 19 | 28 | Under 11 | $1,021 |
| Amlodipine Besylate Generic | 18 | 24 | Under 11 | $32.79 |
| Brukinsa Zanubrutinib | 18 | 18 | Under 11 | $240K |
| Venclexta Venetoclax | 17 | 18 | Under 11 | $43K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 17 | 17 | Under 11 | $1,997 |
| Tamsulosin Hcl Generic | 16 | 26 | Under 11 | $127 |
| Jakafi Ruxolitinib Phosphate | 16 | 16 | Under 11 | $264K |
| Revlimid Lenalidomide | 16 | 16 | Under 11 | $342K |
| Ondansetron Hcl Generic | 16 | 16 | Under 11 | $150 |
| Oxycodone Hcl Generic | 15 | 15 | Under 11 | $860 |
| Famotidine Generic | 15 | 33 | Under 11 | $81.19 |
| Montelukast Sodium Generic | 15 | 27 | Under 11 | $84.78 |
Brand drugs: 148 claims; generic drugs: 472 claims; opioid claims: 18.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kentaro Minagawa $3,286 ($3,286 in general payments such as food, travel and fees) from 15 companies. The largest payer was Adaptive Biotechnologies Corporation with $1,341.
| Company | Payments | Amount |
|---|---|---|
| Adaptive Biotechnologies Corporation ADPT | 8 | $1,341 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $414 |
| Abbvie Inc. ABBV | 3 | $357 |
| Daiichi Sankyo Inc. 4568.T | 6 | $246 |
| Servier Pharmaceuticals LLC | 2 | $147 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $125 |
| BeOne Medicines USA, Inc. ONC | 1 | $123 |
| Astellas Pharma US Inc 4503.T | 1 | $110 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $107 |
| Rigel Pharmaceuticals, Inc. RIGL | 1 | $103 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.